Sethera Therapeutics’ Polymacrocyclic Peptide Platform Selected for CDMRP-Supported Mutant p53 Breast Cancer Program
The award supports innovative, high-impact research aimed at advancing the prevention, diagnosis, and treatment of breast cancer.
Posted in BioUtah News
Tagged Sethera Therapeutics
Comments Off on Sethera Therapeutics’ Polymacrocyclic Peptide Platform Selected for CDMRP-Supported Mutant p53 Breast Cancer Program
Receptor.AI, Sethera Plan to Create Closed-Loop Discovery, Optimization Workflow for Difficult Therapeutic Targets
Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow.
Posted in BioUtah News
Tagged Sethera Therapeutics
Comments Off on Receptor.AI, Sethera Plan to Create Closed-Loop Discovery, Optimization Workflow for Difficult Therapeutic Targets
Dr. Robert Langer and Brigadier General Larry Lunt Join Forces with Sethera
World-Renowned Scientist and Co-founder of Moderna, Dr. Robert Langer, to Guide Sethera’s Scientific Strategy; Brigadier General Larry V. Lunt, USAF (Ret.), Adds Decades of Strategic Leadership Experience to Sethera’s Board
Posted in BioUtah News
Tagged Sethera Therapeutics
Comments Off on Dr. Robert Langer and Brigadier General Larry Lunt Join Forces with Sethera
Sethera Therapeutics Completes First Funding Round
Sethera Therapeutics Completes First Funding Round
Posted in BioUtah News
Tagged Sethera Therapeutics
Comments Off on Sethera Therapeutics Completes First Funding Round
